Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Palliation
What are your preferred dose/fractionation options for treatment of hemoptysis related to central lung metastasis?
Does your management change if the primary tumor is radioresistant, such as renal cell carcinoma?
Answer from: Radiation Oncologist at Community Practice
50 Gy in 5 fractions every other day with SBRT.
Sign in or Register to read more
15235
Related Questions
Is there a role for radiation in palliating malignant small bowel obstruction?
Does your choice of dose and fractionation for bone metastasis depend on the location of the metastasis in question?
Do you constrain heterogeneity or hotspots when delivering spine SBRT for bone metastases?
Do you use a comprehensive volumetric, rather than numeric, cutoff in consideration of SRS vs WBRT for brain metastases?
Would you offer 12-16 Gy in a single fraction for a symptomatic, non-vertebral bone metastasis?
How would you manage a patient with a high-risk asymptomatic bone metastasis with a driver mutation?
What is the expected timeframe for the development of radiation myelitis and therapies that have helped with neurologic symptoms?
Would you consider palliative RT in the setting of tumor causing osteonecrosis in an elderly patient?
What is the optimal management of pain and loss of function due to pathologic compression fractures?
What screening tools or signs do you use to predict if a cancer patient is near end-of-life?